The RNA-binding protein FUS/TLS undergoes calcium-mediated nuclear egress during excitotoxic stress and is required for GRIA2 mRNA processing
Authors
Tischbein, MaeveBaron, Desiree M.
Lin, Yen-Chen
Gall, Katherine V.
Landers, John E.
Fallini, Claudia
Bosco, Daryl A.
Document Type
Journal ArticlePublication Date
2019-05-15Keywords
RNA transportamyotrophic lateral sclerosis (ALS) (Lou Gehrig disease)
excitatory neurotransmission
excitotoxicity
fused in sarcoma/translocated in liposarcoma (FUS/TLS)
glutamate
glutamate ionotropic receptor AMPA type subunit 2 (Gria2)
glutamate receptor 2 (GluA2)
neurodegeneration
nucleocytoplasmic transport
Amino Acids, Peptides, and Proteins
Biochemistry
Molecular Biology
Nervous System Diseases
Neuroscience and Neurobiology
Nucleic Acids, Nucleotides, and Nucleosides
Metadata
Show full item recordAbstract
Excitotoxic levels of glutamate represent a physiological stress that is strongly linked to amyotrophic lateral sclerosis (ALS) and other neurological disorders. Emerging evidence indicates a role for neurodegenerative disease-linked RNA-binding proteins (RBPs) in the cellular stress response. However, the relationships between excitotoxicity, RBP function, and disease have not been explored. Here, using primary cortical and motor neurons, we found that excitotoxicity induced the translocation of select ALS-linked RBPs from the nucleus to the cytoplasm within neurons. RBPs affected by excitotoxicity included TAR DNA-binding protein 43 (TDP-43) and, most robustly, fused in sarcoma/translocated in liposarcoma (FUS/TLS). We noted that FUS is translocated through a calcium-dependent mechanism and that its translocation coincides with striking alterations in nucleocytoplasmic transport. Further, glutamate-induced up-regulation of glutamate ionotropic receptor AMPA type subunit 2 (GRIA2) in neurons depended on FUS expression, consistent with a functional role for FUS in excitotoxic stress. These findings reveal molecular links among prominent factors in neurodegenerative diseases, namely excitotoxicity, disease-associated RBPs, and nucleocytoplasmic transport.Source
J Biol Chem. 2019 May 15. pii: jbc.RA118.005933. doi: 10.1074/jbc.RA118.005933. [Epub ahead of print] Link to article on publisher's site
DOI
10.1074/jbc.RA118.005933Permanent Link to this Item
http://hdl.handle.net/20.500.14038/41060PubMed ID
31092554Related Resources
Rights
© 2019 by The American Society for Biochemistry and Molecular Biology, Inc. Publisher PDF posted after 12 months as allowed by the publisher's author rights policy at http://www.jbc.org/site/misc/edpolicy.xhtml#copyright.ae974a485f413a2113503eed53cd6c53
10.1074/jbc.RA118.005933